Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat

B. H. Hirst, J. D. Reed, B. Shaw, D. H. Coy, Andrew V Schally

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

Somatostatin inhibition of gastric acid and pepsin secretion stimulated by insulin-hypoglycaemia was quantified in six conscious cats prepared with cannulated gastric fistulae. Somatostatin 0.5-5μg kg -1 h -1 produced a dose dependent reduction of both acid and pepsin secretions stimulated by insulin 0.2 u kg -1 h -1. The doses of somatostatin which produced 50% inhibition of pepsin and acid secretions (ID 50) were not significntly different (0.70 ± 0.16 and 0.93 ± 0.11 μg kg -1h -1 respectively). The slope of the calculated correlation line relating % inhibition of pepsin and % inhibition of acid is within experimental error of unity indicating equality of action of somatostatin on insulin-stimulated acid and pepsin secretion. The results indicate that somatostatin is a more potent inhibitior of insulin 0.2 μ kg -1h -1 stimulated acid secretion than pentagastrin 8μg kg -1 h -1 stimulated acid secretion, but is a more potent inhibitor of pentagastrin insulin - stimulated pepsin secretion. As insulin stimulates less acid and more pepsin secretion than pentagastrin, the differences in sensitivities to somatostatin of these secretions produced by the two stimulants is thought to be a result of the different absolute amounts of secretion produced by the stimulants.

Original languageEnglish
Title of host publicationActa Hepato-Gastroenterologica
Pages208-212
Number of pages5
Volume25
Edition3
StatePublished - Dec 1 1978
Externally publishedYes

Fingerprint

Pepsin A
Gastric Acid
Somatostatin
Cats
Insulin
Acids
Pentagastrin
Gastric Fistula
Hypoglycemia

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hirst, B. H., Reed, J. D., Shaw, B., Coy, D. H., & Schally, A. V. (1978). Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat. In Acta Hepato-Gastroenterologica (3 ed., Vol. 25, pp. 208-212)

Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat. / Hirst, B. H.; Reed, J. D.; Shaw, B.; Coy, D. H.; Schally, Andrew V.

Acta Hepato-Gastroenterologica. Vol. 25 3. ed. 1978. p. 208-212.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hirst, BH, Reed, JD, Shaw, B, Coy, DH & Schally, AV 1978, Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat. in Acta Hepato-Gastroenterologica. 3 edn, vol. 25, pp. 208-212.
Hirst BH, Reed JD, Shaw B, Coy DH, Schally AV. Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat. In Acta Hepato-Gastroenterologica. 3 ed. Vol. 25. 1978. p. 208-212
Hirst, B. H. ; Reed, J. D. ; Shaw, B. ; Coy, D. H. ; Schally, Andrew V. / Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat. Acta Hepato-Gastroenterologica. Vol. 25 3. ed. 1978. pp. 208-212
@inbook{c2c67803cc5e43b48e34a31443f7072c,
title = "Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat",
abstract = "Somatostatin inhibition of gastric acid and pepsin secretion stimulated by insulin-hypoglycaemia was quantified in six conscious cats prepared with cannulated gastric fistulae. Somatostatin 0.5-5μg kg -1 h -1 produced a dose dependent reduction of both acid and pepsin secretions stimulated by insulin 0.2 u kg -1 h -1. The doses of somatostatin which produced 50{\%} inhibition of pepsin and acid secretions (ID 50) were not significntly different (0.70 ± 0.16 and 0.93 ± 0.11 μg kg -1h -1 respectively). The slope of the calculated correlation line relating {\%} inhibition of pepsin and {\%} inhibition of acid is within experimental error of unity indicating equality of action of somatostatin on insulin-stimulated acid and pepsin secretion. The results indicate that somatostatin is a more potent inhibitior of insulin 0.2 μ kg -1h -1 stimulated acid secretion than pentagastrin 8μg kg -1 h -1 stimulated acid secretion, but is a more potent inhibitor of pentagastrin insulin - stimulated pepsin secretion. As insulin stimulates less acid and more pepsin secretion than pentagastrin, the differences in sensitivities to somatostatin of these secretions produced by the two stimulants is thought to be a result of the different absolute amounts of secretion produced by the stimulants.",
author = "Hirst, {B. H.} and Reed, {J. D.} and B. Shaw and Coy, {D. H.} and Schally, {Andrew V}",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "25",
pages = "208--212",
booktitle = "Acta Hepato-Gastroenterologica",
edition = "3",

}

TY - CHAP

T1 - Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat

AU - Hirst, B. H.

AU - Reed, J. D.

AU - Shaw, B.

AU - Coy, D. H.

AU - Schally, Andrew V

PY - 1978/12/1

Y1 - 1978/12/1

N2 - Somatostatin inhibition of gastric acid and pepsin secretion stimulated by insulin-hypoglycaemia was quantified in six conscious cats prepared with cannulated gastric fistulae. Somatostatin 0.5-5μg kg -1 h -1 produced a dose dependent reduction of both acid and pepsin secretions stimulated by insulin 0.2 u kg -1 h -1. The doses of somatostatin which produced 50% inhibition of pepsin and acid secretions (ID 50) were not significntly different (0.70 ± 0.16 and 0.93 ± 0.11 μg kg -1h -1 respectively). The slope of the calculated correlation line relating % inhibition of pepsin and % inhibition of acid is within experimental error of unity indicating equality of action of somatostatin on insulin-stimulated acid and pepsin secretion. The results indicate that somatostatin is a more potent inhibitior of insulin 0.2 μ kg -1h -1 stimulated acid secretion than pentagastrin 8μg kg -1 h -1 stimulated acid secretion, but is a more potent inhibitor of pentagastrin insulin - stimulated pepsin secretion. As insulin stimulates less acid and more pepsin secretion than pentagastrin, the differences in sensitivities to somatostatin of these secretions produced by the two stimulants is thought to be a result of the different absolute amounts of secretion produced by the stimulants.

AB - Somatostatin inhibition of gastric acid and pepsin secretion stimulated by insulin-hypoglycaemia was quantified in six conscious cats prepared with cannulated gastric fistulae. Somatostatin 0.5-5μg kg -1 h -1 produced a dose dependent reduction of both acid and pepsin secretions stimulated by insulin 0.2 u kg -1 h -1. The doses of somatostatin which produced 50% inhibition of pepsin and acid secretions (ID 50) were not significntly different (0.70 ± 0.16 and 0.93 ± 0.11 μg kg -1h -1 respectively). The slope of the calculated correlation line relating % inhibition of pepsin and % inhibition of acid is within experimental error of unity indicating equality of action of somatostatin on insulin-stimulated acid and pepsin secretion. The results indicate that somatostatin is a more potent inhibitior of insulin 0.2 μ kg -1h -1 stimulated acid secretion than pentagastrin 8μg kg -1 h -1 stimulated acid secretion, but is a more potent inhibitor of pentagastrin insulin - stimulated pepsin secretion. As insulin stimulates less acid and more pepsin secretion than pentagastrin, the differences in sensitivities to somatostatin of these secretions produced by the two stimulants is thought to be a result of the different absolute amounts of secretion produced by the stimulants.

UR - http://www.scopus.com/inward/record.url?scp=0018190474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018190474&partnerID=8YFLogxK

M3 - Chapter

C2 - 352081

AN - SCOPUS:0018190474

VL - 25

SP - 208

EP - 212

BT - Acta Hepato-Gastroenterologica

ER -